|
【1】Beal M.F.: Energetics in the pathogenesis of neurodegenerative diseases.Trends Neurosci. 23: 298-304; 2000. 【2】Friedland R.P. (1993) Alzheimer's disease: clinical features and differential diagnosis. Neurology 43: S45-S52. 【3】Yoshioka, K., Miki, T., Katsuya, T. et al. (1991) The 717Val—Ile substitution in the amyloid precursor protein is associated with familial AD regardless of the ethnic group. Biochem Biophys Res Commun 178:1141-1146. 【4】Murrell, J., Farlow, M., Ghetti, B. and Benson, M.D. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimers disease. Science 254: 97-99. 【5】Chartier-Harlin, M.C., Grawford, F., Houlden, H. et al. (1991) Early-onset Alzheimer's disease caused by a mutation at codon 717 of the ß-amyloid precursor protein gene. Nature 353: 844-846. 【6】Sukanto,S., Ivan,L. (1999) Cellular mechanisms of β-amyloid production and secretion. PNAS 96:11049-11053. 【7】Van Broeckhoven, C. (1995) Presenilins and Alzheimer's Disease. Nat.Genet. 11: 230-232. 【8】Sherrington, R. et al. (1995) Cloning of a novel gene bearing missense mutations in early onset familial and sporadic Alzheimer’s disease. Nature 375: 754-760. 【9】Levy-Lahad, E. et al. (1995) Candidate gene for the chromosome I familial Alzheimer’s disease locus. Science 269: 973-977. 【10】Rogaev, E.. I. Et al. (1995) Familial Alzheimer’s disease in kindreds with missense mutation in a gene on chromosome I related to the Alzheimer’s disease type 3 gene. Nature 379: 775-778. 【11】Florence,R., Philippe,A., (2000) Genetic susceptibility factors for Alzheimer’s disease. European Journal of Pharmacology 412:1-12. 【12】Warren,J.S. Et al.(1993) Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. PNAS 90: 1977-1981. 【13】William,G. Et al (2003) Apoptosis in Parkinson’s disease: signals for neuronal degradation. annals of neurology 53: S61-S72. 【14】Joseph,W., Et al (2004) Parkinson’s disease in ireland: clinical presentation and genetic heterogeneity in patients with Parkin Mutations. Movement Disorders 19:677-681. 【15】Parkinson J. An essay on the shaking palsy. London: Whittingham and Rowalnad for Sherwood , Neelyand Jones . 1817 . 【16】Steven,D., Kenneth,M. (2003) Looking backward to move forward: Early detection of neurodegenerative disorders. Science 302: 830-834 【17】Brouillet E, Conde F, Beal MF, Hantraye P: Replicating Huntington’s disease phenotype in experimental animals. Prog. Neurobiol. 59:427-468; 1999. 【18】Huntington’s Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971-983; 1993. 【19】Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257. 【20】Cynthia Gibas, Per Jambeck 原著 ;李士杰、林仲彥、陳淑華 & OSB-TW 譯,生物資訊學電腦技術,初版,台北市,歐萊禮,2002年 【21】Minoru,K., Susumu,G., (2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research 28: 27-30. 【22】Barkur S., (2003) Neurodegenerative disorders of protein aggregation. Neurochemistry International 43: 1-7 【23】R. Allen Wyke, Donald B. Thomas 原著; 吳東賢 譯,Perl 程式設計入門手冊,初版,台北市,麥格羅希爾,2001年 【24】T. Pfeiffer, I. Sanchez-Valdenebro, J.C. Nuno, F. Montero, S. Schuster(1999) : METATOOL: for studying metabolic networks. BIOINFORMATICS 15:251-257. 【25】A.Rzhetsky:(2000) A knowledge model for analysis and simulation of regulatory networks. BIOINFORMATICS 16:1120-1128. 【26】A.Geosmann: (2002). PathFinder: reconstruction and dynamic visualization of metabolic pathways. BIOINFORMATICS 18:124-129.
|